Seelos Therapeutics Inc.

0.37
-0.17 (-31.49%)
At close: Nov 18, 2024, 8:58 PM

Seelos Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97
Net Income -37.88M -73.53M -66.05M -19.1M -51.26M -9.22M -11.75M -7.43M -19.02M -22.48M -15.87M -25.56M -18.12M -29.51M -32.04M -5.17M -8.79M -8.04M -15.44M -17.02M -17.23M -27.64M -16.17M -8.72M -2.5M -4.78M -3.86M
Depreciation & Amortization 57K 53K 1.58M 150K n/a 41K 117K 289K 300K 170K 77K 203K 602.33K 989.24K 387.71K 486.42K 1.03M 1.17M 1.27M 996.04K 1.25M 1.07M 527.01K 257.15K 100K 341.22K 31.68K
Stock-Based Compensation 3.99M 5.07M 8.35M 2.04M 459K 1.3M 1.14M 1.75M 1.21M 1.73M 1.99M 2.92M n/a 2.34M 902.67K 1.32M 1.36M 1.36M 82.21K n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital -358K 850K -1.21M -5.64M 8.29M -498K -498K -210K -2.89M -625K 239K -720K 1.16M 285.86K -74.16K -949.96K 1.23M -1.52M 4.7M -557.12K -3.35M 2.71M 887.25K 2.06M -1M 115.71K 599.18K
Other Non-Cash Items -2.49M 4.02M 10.11M 689K 24.63M 92K 58K 823K 317K 5.16M 89K 7.26M 5.54M 204.9K 29.26M 1.6M 1.16M 1.36M 98.58K 1.36M 3.79M 632.01K 625.39K 84.86K -1.1M -151.85K 177.43K
Deferred Income Tax n/a n/a -1.58M -150K n/a -24K 1.17M -7.47M -3.13M -1.35M -584K 1.26M n/a 18.9M -934.02K -15.35 -1.34M -885.09K -82.21K -3.16 n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital 12.42M 2.78M -1.41M -4.54M 6.86M -321K -1.2M -1.02M -2.31M -1.25M -769K -477K 2.25M 189.34K -1.08M -949.96K -6.36K -1.63M 4.24M -557.12K -3.35M 2.71M 887.25K 2.06M -1M -583.95K 599.18K
Operating Cash Flow -23.91M -61.6M -48.99M -20.91M -19.3M -8.13M -10.47M -13.07M -22.64M -18.02M -15.06M -14.39M -9.72M -6.89M -3.51M -2.71M -6.59M -6.67M -9.84M -15.23M -15.55M -23.23M -14.14M -6.32M -4.5M -5.17M -3.05M
Capital Expenditures n/a n/a n/a n/a n/a n/a n/a -18K -337K -580K -573K -436K -262.75K -436.96K -5.53K -28.99K -100.88K -76.55K -160.69K -145.81K -441.3K -3.59M -3.82M -3.31M -200K -498.76K -147.13K
Acquisitions n/a n/a n/a n/a n/a n/a n/a 3K 5K 50K 255K 1.8M 107.17K n/a n/a n/a -178.77K n/a n/a n/a n/a n/a n/a n/a n/a -1.87M -1.57M
Purchase of Investments n/a n/a n/a 6.37M 5.92M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -3M -6M -1.5M -1.9M -1.5M -3.61M -5.88M -23.37M n/a -150K n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 750K 3.25M 5.5M 2.38M 1.01M 743.55K 8.76M 8.13M 15.16M n/a 498.76K n/a
Other Investing Acitivies n/a n/a n/a n/a n/a -3K 12.21M 283K 5K 675K 5.03M -300K n/a 1.39K 350K 75K 178.77K 178.77K n/a 48.34K n/a -246.69K n/a n/a 300K 3.24M n/a
Investing Cash Flow n/a n/a n/a 6.37M 5.92M -3K 12.21M 265K -332K 145K 4.71M 1.07M -155.58K -435.57K 344.47K 796.01K 149.13K -397.78K 723.31K -984.97K -1.2M 1.32M -1.57M -11.52M 100K 1.22M -1.72M
Debt Repayment -7.64M -1.89M -13.55M 147K n/a n/a -7.13M n/a 4.5M 1.95M -27K -587K -416.91K 15.02M 636.08K 1.58M -2.11M -1.26M -644.05K -898.86K 6.63M 5.4M -101.34K -133.84K -100K 2.2M 2.6M
Common Stock Repurchased -1.2M n/a n/a n/a n/a n/a n/a n/a n/a -42K n/a n/a n/a n/a n/a n/a -2.11K n/a -92.03K n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -15.26K -15.26K -123.33K n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 97K -166K 7.46M 45K 4.52M 585K -1.1M -3.76M 93K 42K 46K 956K 1.93M -10.67M n/a 459.75K 15.26K n/a n/a n/a n/a n/a n/a -33.09K -500K 78.42K n/a
Financial Cash Flow 11.38M -1.6M 112.07M 26.31M 29.52M 5.38M 2.5M 11M 15.46M 7.87M 16.63M 20.78M 8.17M 15.99M 636.08K 2.04M -1.89M 15.18M 4.32M 13.49M 25.19M 10.04M 918.46K 40.42M 7.8M 5.46M 4.7M
Net Cash Flow -12.54M -63.2M 63.07M 5.4M 10.22M -2.75M 4.24M -1.8M -7.51M -10.01M 6.28M 7.7M -1.71M 8.67M -2.53M 127.02K -8.33M 8.12M -4.79M -2.73M 8.44M -11.88M -14.79M 22.58M 3.4M 1.55M -61.39K
Free Cash Flow -23.91M -61.6M -48.99M -20.91M -19.3M -8.13M -10.47M -13.09M -22.98M -18.59M -15.64M -14.83M -9.99M -7.33M -3.52M -2.74M -6.69M -6.74M -10M -15.37M -15.99M -26.82M -17.96M -9.63M -4.7M -5.67M -3.2M